CA2069534A1 - Method for regulating enzyme activities by noble gases - Google Patents
Method for regulating enzyme activities by noble gasesInfo
- Publication number
- CA2069534A1 CA2069534A1 CA002069534A CA2069534A CA2069534A1 CA 2069534 A1 CA2069534 A1 CA 2069534A1 CA 002069534 A CA002069534 A CA 002069534A CA 2069534 A CA2069534 A CA 2069534A CA 2069534 A1 CA2069534 A1 CA 2069534A1
- Authority
- CA
- Canada
- Prior art keywords
- enzymes
- gas
- enzyme
- noble gases
- xenon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 143
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 143
- 230000000694 effects Effects 0.000 title claims abstract description 83
- 238000000034 method Methods 0.000 title claims abstract description 81
- 229910052756 noble gas Inorganic materials 0.000 title claims abstract description 68
- 150000002835 noble gases Chemical class 0.000 title claims abstract description 58
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 48
- 239000007789 gas Substances 0.000 claims abstract description 152
- 239000000203 mixture Substances 0.000 claims abstract description 83
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 113
- 229910052724 xenon Inorganic materials 0.000 claims description 96
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims description 91
- 229910052786 argon Inorganic materials 0.000 claims description 59
- 238000006243 chemical reaction Methods 0.000 claims description 54
- 229910052743 krypton Inorganic materials 0.000 claims description 48
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 claims description 47
- 229910052754 neon Inorganic materials 0.000 claims description 43
- 230000002401 inhibitory effect Effects 0.000 claims description 41
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 claims description 41
- 230000002708 enhancing effect Effects 0.000 claims description 19
- 239000000758 substrate Substances 0.000 claims description 18
- 102000004316 Oxidoreductases Human genes 0.000 claims description 14
- 108090000854 Oxidoreductases Proteins 0.000 claims description 14
- 102000004317 Lyases Human genes 0.000 claims description 12
- 108090000856 Lyases Proteins 0.000 claims description 12
- 230000002255 enzymatic effect Effects 0.000 claims description 12
- 102000004157 Hydrolases Human genes 0.000 claims description 11
- 108090000604 Hydrolases Proteins 0.000 claims description 11
- 102000004195 Isomerases Human genes 0.000 claims description 10
- 108090000769 Isomerases Proteins 0.000 claims description 10
- 102000003960 Ligases Human genes 0.000 claims description 10
- 108090000364 Ligases Proteins 0.000 claims description 10
- 102000004357 Transferases Human genes 0.000 claims description 9
- 108090000992 Transferases Proteins 0.000 claims description 9
- 230000007704 transition Effects 0.000 claims description 8
- 239000006185 dispersion Substances 0.000 claims description 7
- 239000011159 matrix material Substances 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 4
- 239000003623 enhancer Substances 0.000 claims description 3
- 238000006911 enzymatic reaction Methods 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- CQARAIRTGMAYMZ-IBGZPJMESA-N (4S)-5-amino-5-oxo-4-[3-[4-(5-phenylthiophen-2-yl)phenyl]propanoylamino]pentanoic acid Chemical compound C1=CC(CCC(=O)N[C@@H](CCC(O)=O)C(=O)N)=CC=C1C1=CC=C(C=2C=CC=CC=2)S1 CQARAIRTGMAYMZ-IBGZPJMESA-N 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 101
- 229940088598 enzyme Drugs 0.000 description 94
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 65
- 229910052760 oxygen Inorganic materials 0.000 description 60
- 239000001301 oxygen Substances 0.000 description 60
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 59
- 239000000243 solution Substances 0.000 description 47
- 102000003425 Tyrosinase Human genes 0.000 description 46
- 108060008724 Tyrosinase Proteins 0.000 description 46
- 239000011734 sodium Substances 0.000 description 45
- 230000005764 inhibitory process Effects 0.000 description 39
- 229910052757 nitrogen Inorganic materials 0.000 description 32
- 229960004441 tyrosine Drugs 0.000 description 21
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 18
- 239000000872 buffer Substances 0.000 description 13
- 150000002500 ions Chemical class 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 239000011261 inert gas Substances 0.000 description 10
- 230000009471 action Effects 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Chemical compound OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 229910001868 water Inorganic materials 0.000 description 8
- 108010056771 Glucosidases Proteins 0.000 description 7
- 102000004366 Glucosidases Human genes 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 7
- 101150034533 ATIC gene Proteins 0.000 description 6
- 108010078791 Carrier Proteins Proteins 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000002706 hydrostatic effect Effects 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 229910000162 sodium phosphate Inorganic materials 0.000 description 6
- 210000003719 b-lymphocyte Anatomy 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000001488 sodium phosphate Substances 0.000 description 5
- 235000011008 sodium phosphates Nutrition 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 5
- 241000518994 Conta Species 0.000 description 4
- 108091036429 KCNQ1OT1 Proteins 0.000 description 4
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 102100025490 Slit homolog 1 protein Human genes 0.000 description 4
- 101710123186 Slit homolog 1 protein Proteins 0.000 description 4
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 4
- 239000001307 helium Substances 0.000 description 4
- 229910052734 helium Inorganic materials 0.000 description 4
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 229910052704 radon Inorganic materials 0.000 description 4
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- ZPEZUAAEBBHXBT-WCCKRBBISA-N (2s)-2-amino-3-methylbutanoic acid;2-amino-3-methylbutanoic acid Chemical compound CC(C)C(N)C(O)=O.CC(C)[C@H](N)C(O)=O ZPEZUAAEBBHXBT-WCCKRBBISA-N 0.000 description 2
- 210000003771 C cell Anatomy 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 2
- 108010087806 Carnosine Proteins 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 101100346656 Drosophila melanogaster strat gene Proteins 0.000 description 2
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 2
- 241001364889 Helius Species 0.000 description 2
- 101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102100034866 Kallikrein-6 Human genes 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 241001072332 Monia Species 0.000 description 2
- 101100270435 Mus musculus Arhgef12 gene Proteins 0.000 description 2
- 101100400378 Mus musculus Marveld2 gene Proteins 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 2
- 208000010513 Stupor Diseases 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- -1 Xrypton Chemical compound 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 229940044199 carnosine Drugs 0.000 description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000009189 diving Effects 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000001272 nitrous oxide Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 2
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 2
- 229940120668 salicin Drugs 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- NYPYHUZRZVSYKL-UHFFFAOYSA-N -3,5-Diiodotyrosine Natural products OC(=O)C(N)CC1=CC(I)=C(O)C(I)=C1 NYPYHUZRZVSYKL-UHFFFAOYSA-N 0.000 description 1
- NYPYHUZRZVSYKL-ZETCQYMHSA-N 3,5-diiodo-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC(I)=C(O)C(I)=C1 NYPYHUZRZVSYKL-ZETCQYMHSA-N 0.000 description 1
- WJXSWCUQABXPFS-UHFFFAOYSA-N 3-hydroxyanthranilic acid Chemical compound NC1=C(O)C=CC=C1C(O)=O WJXSWCUQABXPFS-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000003677 Aldehyde-Lyases Human genes 0.000 description 1
- 108090000072 Aldehyde-Lyases Proteins 0.000 description 1
- XUHLIQGRKRUKPH-GCXOYZPQSA-N Alliin Natural products N[C@H](C[S@@](=O)CC=C)C(O)=O XUHLIQGRKRUKPH-GCXOYZPQSA-N 0.000 description 1
- 108090000673 Ammonia-Lyases Proteins 0.000 description 1
- 102000004118 Ammonia-Lyases Human genes 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000217177 Anacolosa luzoniensis Species 0.000 description 1
- 235000007911 Anacolosa luzoniensis Nutrition 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 244000125300 Argania sideroxylon Species 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 101100325905 Bacillus licheniformis (strain ATCC 14580 / DSM 13 / JCM 2505 / CCUG 7422 / NBRC 12200 / NCIMB 9375 / NCTC 10341 / NRRL NRS-1264 / Gibson 46) lacA gene Proteins 0.000 description 1
- 101100325906 Bacillus subtilis (strain 168) ganA gene Proteins 0.000 description 1
- 101100447914 Caenorhabditis elegans gab-1 gene Proteins 0.000 description 1
- 101100121964 Caenorhabditis elegans glit-1 gene Proteins 0.000 description 1
- 241000178335 Caldicellulosiruptor saccharolyticus Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000511343 Chondrostoma nasus Species 0.000 description 1
- 241000272470 Circus Species 0.000 description 1
- 102000005870 Coenzyme A Ligases Human genes 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- 102000018361 Contactin Human genes 0.000 description 1
- 108060003955 Contactin Proteins 0.000 description 1
- 241001442234 Cosa Species 0.000 description 1
- 108010031700 Cytochrome-c3 hydrogenase Proteins 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- 150000008151 D-glucosides Chemical class 0.000 description 1
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 1
- 241000283014 Dama Species 0.000 description 1
- 101100130497 Drosophila melanogaster Mical gene Proteins 0.000 description 1
- 101100137177 Drosophila melanogaster polyph gene Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 101000852543 Homo sapiens Importin-4 Proteins 0.000 description 1
- 108030003948 Hypotaurine dehydrogenases Proteins 0.000 description 1
- 241000188250 Idas Species 0.000 description 1
- 102100036341 Importin-4 Human genes 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 101100017408 Lactococcus lactis subsp. cremoris (strain MG1363) hisP gene Proteins 0.000 description 1
- 108010011449 Long-chain-fatty-acid-CoA ligase Proteins 0.000 description 1
- 101150057104 MCIDAS gene Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 101100001347 Mus musculus Akt1s1 gene Proteins 0.000 description 1
- 101100345589 Mus musculus Mical1 gene Proteins 0.000 description 1
- 101100192716 Mus musculus Purg gene Proteins 0.000 description 1
- 101100248652 Mus musculus Rinl gene Proteins 0.000 description 1
- GVOIQSXBMLNCLC-UHFFFAOYSA-N OOOS Chemical compound OOOS GVOIQSXBMLNCLC-UHFFFAOYSA-N 0.000 description 1
- 101150012394 PHO5 gene Proteins 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000056222 Peptide Synthases Human genes 0.000 description 1
- 108700018928 Peptide Synthases Proteins 0.000 description 1
- 108090000279 Peptidyltransferases Proteins 0.000 description 1
- 102000017795 Perilipin-1 Human genes 0.000 description 1
- 108010067162 Perilipin-1 Proteins 0.000 description 1
- 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 description 1
- 108030001966 Phloretin hydrolases Proteins 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- XUHLIQGRKRUKPH-UHFFFAOYSA-N S-allyl-L-cysteine sulfoxide Natural products OC(=O)C(N)CS(=O)CC=C XUHLIQGRKRUKPH-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000950638 Symphysodon discus Species 0.000 description 1
- 241001399969 Syntheta Species 0.000 description 1
- 108010041155 Taurine dehydrogenase Proteins 0.000 description 1
- 102100033227 Teneurin-2 Human genes 0.000 description 1
- 101710122316 Teneurin-2 Proteins 0.000 description 1
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
- 102000016540 Tyrosine aminotransferases Human genes 0.000 description 1
- 108010042606 Tyrosine transaminase Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 108030006907 Ureidosuccinases Proteins 0.000 description 1
- 108091007416 X-inactive specific transcript Proteins 0.000 description 1
- 108091035715 XIST (gene) Proteins 0.000 description 1
- JXBFBSYDINUVRE-UHFFFAOYSA-N [Ne].[Ar] Chemical compound [Ne].[Ar] JXBFBSYDINUVRE-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- XUHLIQGRKRUKPH-DYEAUMGKSA-N alliin Chemical compound OC(=O)[C@@H](N)C[S@@](=O)CC=C XUHLIQGRKRUKPH-DYEAUMGKSA-N 0.000 description 1
- 235000015295 alliin Nutrition 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- QXAITBQSYVNQDR-UHFFFAOYSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1N=CN(C)C=NC1=CC=C(C)C=C1C QXAITBQSYVNQDR-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- DMLAVOWQYNRWNQ-UHFFFAOYSA-N azobenzene Chemical compound C1=CC=CC=C1N=NC1=CC=CC=C1 DMLAVOWQYNRWNQ-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000002844 continuous effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- KFWWCMJSYSSPSK-PAXLJYGASA-N crotonoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 KFWWCMJSYSSPSK-PAXLJYGASA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- JNSGIVNNHKGGRU-JYRVWZFOSA-N diethoxyphosphinothioyl (2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetate Chemical compound CCOP(=S)(OCC)OC(=O)C(=N/OC)\C1=CSC(N)=N1 JNSGIVNNHKGGRU-JYRVWZFOSA-N 0.000 description 1
- DMSHWWDRAYHEBS-UHFFFAOYSA-N dihydrocoumarin Natural products C1CC(=O)OC2=C1C=C(OC)C(OC)=C2 DMSHWWDRAYHEBS-UHFFFAOYSA-N 0.000 description 1
- 229960000415 diiodotyrosine Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
- 229960003132 halothane Drugs 0.000 description 1
- AFAUWLCCQOEICZ-UHFFFAOYSA-N helium xenon Chemical compound [He].[Xe] AFAUWLCCQOEICZ-UHFFFAOYSA-N 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000000937 inactivator Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 101150108076 lin28a gene Proteins 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 229940099990 ogen Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009931 pascalization Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 101150039516 ple3 gene Proteins 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000020004 porter Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- HHJTWTPUPVQKNA-PIIMIWFASA-N psychosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O HHJTWTPUPVQKNA-PIIMIWFASA-N 0.000 description 1
- HHJTWTPUPVQKNA-UHFFFAOYSA-N psychosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)COC1OC(CO)C(O)C(O)C1O HHJTWTPUPVQKNA-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000010666 regulation of catalytic activity Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 101150081985 scrib gene Proteins 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 102000012498 secondary active transmembrane transporter activity proteins Human genes 0.000 description 1
- 108040003878 secondary active transmembrane transporter activity proteins Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 108010080511 serum sodium transport inhibitor Proteins 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-L tyrosinate(2-) Chemical compound [O-]C(=O)C(N)CC1=CC=C([O-])C=C1 OUYCCCASQSFEME-UHFFFAOYSA-L 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940030186 xpect Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70658791A | 1991-05-28 | 1991-05-28 | |
US07/706,587 | 1991-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2069534A1 true CA2069534A1 (en) | 1992-11-29 |
Family
ID=24838243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002069534A Abandoned CA2069534A1 (en) | 1991-05-28 | 1992-05-26 | Method for regulating enzyme activities by noble gases |
Country Status (20)
Country | Link |
---|---|
US (2) | US5462861A (en, 2012) |
EP (1) | EP0516549B1 (en, 2012) |
JP (1) | JP3655322B2 (en, 2012) |
KR (1) | KR100226649B1 (en, 2012) |
CN (1) | CN1037980C (en, 2012) |
AR (1) | AR246982A1 (en, 2012) |
AT (1) | ATE244301T1 (en, 2012) |
AU (1) | AU660675B2 (en, 2012) |
BR (1) | BR9202016A (en, 2012) |
CA (1) | CA2069534A1 (en, 2012) |
DE (1) | DE69233112T2 (en, 2012) |
DK (1) | DK0516549T3 (en, 2012) |
ES (1) | ES2202300T3 (en, 2012) |
FI (1) | FI103984B1 (en, 2012) |
HU (1) | HU214697B (en, 2012) |
IL (1) | IL101996A (en, 2012) |
MX (1) | MX9202486A (en, 2012) |
PT (1) | PT516549E (en, 2012) |
TW (1) | TW284788B (en, 2012) |
ZA (1) | ZA923847B (en, 2012) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69324748T2 (de) * | 1992-04-03 | 2000-01-13 | L'air Liquide, S.A. Pour L'etude Et L'exploitation Des Procedes Georges Claude | Verfahren zur verbesserung des aromas und/oder des geschmacks von wein mit edelgasen |
CA2102779A1 (en) * | 1992-04-03 | 1993-10-04 | Kevin C. Spencer | A method of controlling the oxidation of chemicals during storage using noble gases |
FR2742765B1 (fr) * | 1995-12-21 | 1998-02-13 | Armines | Procede d'inactivation irreversible d'enzymes en solution |
US5693354A (en) * | 1996-05-01 | 1997-12-02 | L'air Liquide, Societe Anonyme Pour L'etude Et, L'exploitation Des Procedes Georges Claude | Method of disinfecting fresh vegetables by processing the same with a liquid containing a mixture of argon:carbon dioxide |
US7297800B2 (en) * | 2001-12-27 | 2007-11-20 | Ajinomoto Co., Inc. | Process of producing glutamate derivatives |
CA2714881C (en) | 2002-08-26 | 2012-10-23 | Ajinomoto Co., Inc. | Novel aldolase and production process of substituted .alpha.-keto acids |
CA2507225C (en) | 2002-12-09 | 2012-02-07 | Ajinomoto Co., Inc. | Mutated d-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
JP4944018B2 (ja) * | 2004-06-07 | 2012-05-30 | ノボザイムス アクティーゼルスカブ | 脂肪分解酵素アッセイ |
US7180370B2 (en) * | 2004-09-01 | 2007-02-20 | Micron Technology, Inc. | CMOS amplifiers with frequency compensating capacitors |
US8394624B2 (en) * | 2009-01-30 | 2013-03-12 | American Air Liquide, Inc. | Process for preserving biological materials for extended periods of time |
WO2017035253A1 (en) | 2015-08-24 | 2017-03-02 | The Regents Of The University Of California | Methods and compositions for protein purification and enzyme reaction |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE635601C (de) * | 1933-08-01 | 1936-09-21 | Francesco Illy | Verfahren zum Frischhalten von geroestetem, gegebenenfalls gemahlenem Kaffee |
GB415656A (en) * | 1934-02-17 | 1934-08-30 | Francesco Illy | Improved processes for preserving roasted or roasted and ground coffee |
US2569217A (en) * | 1949-05-02 | 1951-09-25 | Aram A Arabian | Method and package for preserving food |
US3143471A (en) * | 1962-01-18 | 1964-08-04 | Merck & Co Inc | Argon method of drying and preserving lyophilized therapeutic products |
US3183171A (en) * | 1962-07-24 | 1965-05-11 | Union Carbide Corp | Process for controlling the growth rate of fungi |
FR1339669A (fr) * | 1962-08-31 | 1963-10-11 | Air Liquide | Procédé de stabilisation de produits altérables à l'air |
FR1454653A (fr) * | 1964-10-29 | 1966-02-11 | Yissum Res Dev Co | Procédé de production de peptides |
US3378443A (en) * | 1966-04-05 | 1968-04-16 | American Cyanamid Co | Anhydrous liquid suspensions of biologics |
US4044004A (en) * | 1968-11-22 | 1977-08-23 | Hoffmann-La Roche Inc. | Total steroid synthesis employing substituted isoxazole derivatives |
US3677024A (en) * | 1970-01-20 | 1972-07-18 | Paul E Segall | Preservation and storage of biologic materials |
US3725076A (en) * | 1970-12-21 | 1973-04-03 | Gen Foods Corp | Coffee of improved aroma and freshness retention |
FR2194418B2 (en, 2012) * | 1971-08-02 | 1977-01-28 | Sada Pietro | |
BE787573A (fr) * | 1971-10-22 | 1973-02-14 | Hag Ag | Procede de fabrication de poudres ayant la couleur de la substance de depart, a partir d'extraits aqueux de produits vegetaux par lyophilisation |
FR2225095A1 (en) * | 1973-04-11 | 1974-11-08 | Inst Scient Tech Alimentat | Packaging roasted coffee in gas-tight packets - with preservative gas to assist aroma retention |
US3957892A (en) * | 1973-05-23 | 1976-05-18 | Ethyl Corporation | Stabilized vinylidene halide |
FR2261518A1 (en) * | 1974-02-20 | 1975-09-12 | Commissariat Energie Atomique | Removal and storage of sodium products - transfer from sealed container for storage in neutral atmosphere |
DE2437812C3 (de) * | 1974-08-06 | 1980-06-26 | Messer Griesheim Gmbh, 6000 Frankfurt | Verfahren zum Konservieren isolierter Organe oder Organteile |
US4138565A (en) * | 1975-05-31 | 1979-02-06 | Sandoz Ltd. | Stable solutions and processes for their preparation |
US4017363A (en) * | 1975-12-19 | 1977-04-12 | Novo Industri A/S | Production of high purity glucose syrups |
JPS5286987A (en) * | 1976-01-14 | 1977-07-20 | Mitsubishi Gas Chem Co Inc | Disoxidant composition |
JPS607609B2 (ja) * | 1976-02-10 | 1985-02-26 | 東亞合成株式会社 | α―シアノアクリル酸エステルの貯蔵方法 |
JPS5319998A (en) * | 1976-08-09 | 1978-02-23 | Toda Kogyo Corp | Process for preparing cobalttdoped acicular magnetite particle having magnetic stability |
FR2406567A1 (fr) * | 1977-10-24 | 1979-05-18 | Dubois Jacques | Procede et dispositif destines a l'emballage etanche sous film thermoplastique et thermoformable de produits exigeant une protection absolue |
JPS54129185A (en) * | 1978-03-30 | 1979-10-06 | Unitika Ltd | Storing of immobilized enzyme |
JPS5516A (en) * | 1978-05-08 | 1980-01-05 | Ajinomoto Co Inc | Production of high concentration dextrin solution |
FR2431860A1 (fr) * | 1978-07-27 | 1980-02-22 | Oreal | Lyophilisats de melanges reactionnels en milieu anaerobie de polhydroxybenzenes et de precurseurs de colorants par oxydation de type para, leur procede de preparation et leur utilisation dans des compositions tinctoriales pour cheveux |
US4501814A (en) * | 1978-10-26 | 1985-02-26 | The Amalgamated Sugar Company | Process for producing a high fructose sweetener, high protein meal, and cereal germ oils |
FR2463780A1 (fr) * | 1979-08-24 | 1981-02-27 | Rhone Poulenc Ind | Procede de preparation de solutions aqueuses d'acides polyacryliques de faibles masses moleculaires ou de leurs sels |
DE3007712C2 (de) * | 1980-02-29 | 1983-12-15 | Rheinmetall GmbH, 4000 Düsseldorf | Verpackung für Treibladungspulver, Treibladungen oder verbrennbare Munitionsformteile |
US4315266A (en) * | 1980-07-25 | 1982-02-09 | Nasa | Spiral slotted phased antenna array |
US4308264A (en) * | 1981-01-28 | 1981-12-29 | Abbott Laboratories | Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration |
JPS5839650A (ja) * | 1981-09-04 | 1983-03-08 | Nippon Kasei Kk | D−2−アミノ−2−(1,4−シクロヘキサジエニル)酢酸の保存方法 |
JPS58107180A (ja) * | 1981-12-17 | 1983-06-25 | Matsushita Electric Ind Co Ltd | 固定化酵素膜の保存方法 |
US4450960A (en) * | 1982-08-30 | 1984-05-29 | Empak Inc. | Package |
JPS5984719A (ja) * | 1982-10-30 | 1984-05-16 | テルモ株式会社 | 長期間変質することのない薬液入りプラスチツク容器の製造方法 |
EP0111595A1 (en) * | 1982-12-22 | 1984-06-27 | Dow Chemical (Belgium) S.A. | Improved method for the production of high fructose corn syrup |
JPS6056984A (ja) * | 1983-09-06 | 1985-04-02 | Nippon Youriyokuso Kk | 天然クロロフィルの製造法 |
US4664256A (en) * | 1983-09-06 | 1987-05-12 | Farmaceutisk Laboratorium Ferring A/S | Packaged stable enema solution or suspension containing 5-aminosalicyclic acid |
US4496397A (en) * | 1984-03-07 | 1985-01-29 | University Of Connecticut | Process for purifying and stabilizing catechol-containing proteins and materials obtained thereby |
SU1289437A1 (ru) * | 1984-08-20 | 1987-02-15 | Казахский научно-исследовательский институт клинической и экспериментальной хирургии им.А.Н.Сызганова | Способ консервации изолированных клеток печени |
US4830858A (en) * | 1985-02-11 | 1989-05-16 | E. R. Squibb & Sons, Inc. | Spray-drying method for preparing liposomes and products produced thereby |
US4643976A (en) * | 1985-06-03 | 1987-02-17 | Ciba Corning Diagnostics Corp. | Liquid clinical control, standard, and reagent products |
US4812320A (en) * | 1986-05-05 | 1989-03-14 | Geo. A. Hormel & Co. | Process for vacuum packaging fresh meat products |
JPS6377848A (ja) * | 1986-09-19 | 1988-04-08 | Kohjin Co Ltd | N,n−ジアルキルアミノプロピル型化合物の安定化法 |
WO1988007676A1 (en) * | 1987-03-27 | 1988-10-06 | Terumo Kabushiki Kaisha | Enzyme sensor |
CA1301533C (en) * | 1987-03-31 | 1992-05-26 | William Duncan Powrie | Preservation of cut and segmented fresh fruit pieces |
CH672996A5 (en, 2012) * | 1987-06-26 | 1990-01-31 | Battelle Memorial Institute | |
JPS6459647A (en) * | 1987-08-31 | 1989-03-07 | Nippon Denki Home Electronics | Objective lens actuator for optical head |
US4919955A (en) * | 1987-09-08 | 1990-04-24 | Mitchell Jerry L | Method for packaging perishable products |
FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
US4892579A (en) * | 1988-04-21 | 1990-01-09 | The Dow Chemical Company | Process for preparing an amorphous alloy body from mixed crystalline elemental metal powders |
US5108656A (en) * | 1988-06-07 | 1992-04-28 | American Air Liquide | Method for preservation of fresh fish or sea-food |
US4946326A (en) * | 1988-06-07 | 1990-08-07 | American Air Liquide | Method for preservation of fresh fish or sea-food |
JPH02104502A (ja) * | 1988-10-13 | 1990-04-17 | Nippon Nohyaku Co Ltd | 水中懸濁状農薬組成物 |
FR2643232A1 (fr) * | 1988-12-16 | 1990-08-24 | Mansour Robert | Methode de protection de beaucoup d'articles durant les periodes de stockage et de conservation, par l'emploi de l'evacuation de l'air suivie par le passage de gaz inerte dans un cycle clos |
US5045529A (en) * | 1989-03-27 | 1991-09-03 | Bionostics, Inc. | Tonometric fluid for blood gas and co-oximetry instruments |
US4965165A (en) * | 1989-05-30 | 1990-10-23 | The Mead Corporation | Donor media shelf life stabilization by control of exposure to contacting oxygen and moisture |
JPH0357689A (ja) * | 1989-07-25 | 1991-03-13 | Brother Ind Ltd | 顕色剤シートの保存方法及び梱包方法 |
FR2652719B1 (fr) * | 1989-10-05 | 1996-07-19 | Air Liquide | Procede de traitement de conservation de produits alimentaires vegetaux frais. |
JPH03200568A (ja) * | 1989-12-28 | 1991-09-02 | Sanden Corp | オイル保管用容器 |
FI102543B (fi) * | 1990-01-04 | 1998-12-31 | Plant Genetic Systems Nv | Mutantti glukoosi-isomeraasit |
US4971813A (en) * | 1990-02-13 | 1990-11-20 | The Procter & Gamble Company | Process for making concentrated low calorie fruit juice |
US5006222A (en) * | 1990-05-23 | 1991-04-09 | Texaco Inc. | Solvent dewaxing of lubricating oils |
US5030778A (en) * | 1990-06-04 | 1991-07-09 | Ethyl Corporation | Decabromodiphenyl alkane process |
US5021251A (en) * | 1990-07-23 | 1991-06-04 | Borden, Inc. | Process for preserving lemon juice utilizating a non-sulfite preservative |
JPH05227699A (ja) * | 1992-02-18 | 1993-09-03 | Aisin Seiki Co Ltd | アクチュエータ装置 |
-
1992
- 1992-05-15 TW TW081103785A patent/TW284788B/zh active
- 1992-05-25 AU AU17116/92A patent/AU660675B2/en not_active Ceased
- 1992-05-25 FI FI922385A patent/FI103984B1/fi active
- 1992-05-26 KR KR1019920008922A patent/KR100226649B1/ko not_active Expired - Fee Related
- 1992-05-26 AR AR92322399A patent/AR246982A1/es active
- 1992-05-26 IL IL101996A patent/IL101996A/xx not_active IP Right Cessation
- 1992-05-26 MX MX9202486A patent/MX9202486A/es not_active IP Right Cessation
- 1992-05-26 CA CA002069534A patent/CA2069534A1/en not_active Abandoned
- 1992-05-26 ZA ZA923847A patent/ZA923847B/xx unknown
- 1992-05-27 CN CN92103909A patent/CN1037980C/zh not_active Expired - Fee Related
- 1992-05-27 BR BR929202016A patent/BR9202016A/pt not_active Application Discontinuation
- 1992-05-27 JP JP16046092A patent/JP3655322B2/ja not_active Expired - Fee Related
- 1992-05-27 HU HU9201767A patent/HU214697B/hu not_active IP Right Cessation
- 1992-05-29 DE DE69233112T patent/DE69233112T2/de not_active Expired - Fee Related
- 1992-05-29 ES ES92401470T patent/ES2202300T3/es not_active Expired - Lifetime
- 1992-05-29 PT PT92401470T patent/PT516549E/pt unknown
- 1992-05-29 AT AT92401470T patent/ATE244301T1/de not_active IP Right Cessation
- 1992-05-29 DK DK92401470T patent/DK0516549T3/da active
- 1992-05-29 EP EP92401470A patent/EP0516549B1/en not_active Expired - Lifetime
-
1993
- 1993-05-17 US US08/062,332 patent/US5462861A/en not_active Expired - Lifetime
-
1995
- 1995-05-22 US US08/445,525 patent/US5707842A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI103984B (fi) | 1999-10-29 |
HUT64585A (en) | 1994-01-28 |
IL101996A (en) | 1997-07-13 |
ES2202300T3 (es) | 2004-04-01 |
FI922385L (fi) | 1992-11-29 |
DE69233112D1 (de) | 2003-08-07 |
CN1068369A (zh) | 1993-01-27 |
AU1711692A (en) | 1992-12-03 |
DK0516549T3 (da) | 2003-10-27 |
HU214697B (hu) | 1998-04-28 |
PT516549E (pt) | 2003-11-28 |
KR100226649B1 (ko) | 1999-10-15 |
HU9201767D0 (en) | 1992-08-28 |
EP0516549A3 (en) | 1993-06-09 |
JPH05328968A (ja) | 1993-12-14 |
JP3655322B2 (ja) | 2005-06-02 |
DE69233112T2 (de) | 2004-04-15 |
US5707842A (en) | 1998-01-13 |
AU660675B2 (en) | 1995-07-06 |
FI103984B1 (fi) | 1999-10-29 |
ZA923847B (en) | 1993-01-27 |
CN1037980C (zh) | 1998-04-08 |
IL101996A0 (en) | 1992-12-30 |
TW284788B (en, 2012) | 1996-09-01 |
EP0516549A2 (en) | 1992-12-02 |
BR9202016A (pt) | 1993-01-26 |
AR246982A1 (es) | 1994-10-31 |
US5462861A (en) | 1995-10-31 |
FI922385A0 (fi) | 1992-05-25 |
MX9202486A (es) | 1992-11-01 |
ATE244301T1 (de) | 2003-07-15 |
EP0516549B1 (en) | 2003-07-02 |
KR920021707A (ko) | 1992-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2069534A1 (en) | Method for regulating enzyme activities by noble gases | |
Blamey et al. | Characterization of an ancestral type of pyruvate ferredoxin oxidoreductase from the hyperthermophilic bacterium, Thermotoga maritima | |
Walde et al. | Structure and activity of trypsin in reverse micelles | |
Andrews et al. | Catalytic properties of a hybrid between cyanobacterial large subunits and higher plant small subunits of ribulose bisphosphate carboxylase-oxygenase. | |
Matthews et al. | Cobalamin‐dependent and cobalamin‐independent methionine synthases: Are there two solutions to the same chemical problem? | |
Erbes et al. | Inactivation of hydrogenase in cell-free extracts and whole cells of Chlamydomonas reinhardi by oxygen | |
Miles et al. | Tyr-143 facilitates interdomain electron transfer in flavocytochrome b 2 | |
Obinger et al. | Purification and Characterization of a Homodimeric Catalase-Peroxidase from the CyanobacteriumAnacystis nidulans | |
Ma et al. | [18] Hydrogenases I and II from Pyrococcus furiosus | |
HIRAOKA et al. | A change of the metal-specific activity of a cambialistic superoxide dismutase from Porphyromonas gingivalis by a double mutation of Gln-70 to Gly and Ala-142 to Gln | |
Bill et al. | Mössbauer Studies on the Active Fe…[2Fe‐2S] Site of Putidamonooxin, Its Electron Transport and Dioxygen Activation Mechanism | |
Hidaka et al. | Evidence of a hydrazine-reactive group at the active site of the nonheme portion of horseradish peroxidase | |
Jensen et al. | Effect of high pN2 and high pD2 on ammonia production, hydrogen evolution, and hydrogen deuteride formation by nitrogenases | |
Arad et al. | The reversal of the Gpp (NH) p-activated state of adenylate cyclase by GTP and hormone is by the “collision coupling” mechanism. | |
Anwaruzzaman et al. | Regulation of ribulose 1, 5-bisphosphate carboxylase/oxygenase activation by inorganic phosphate through stimulating the binding of the activator CO2 to the activation sites | |
Saluja et al. | Modification of active site histidine in ribulose bisphosphate carboxylase oxygenase | |
Peterson et al. | Crystallization and characterization of bovine liver glutamate dehydrogenase | |
Friebel et al. | Oxygen-dependent inactivation of gramicidin S synthetase in Bacillus brevis | |
EP1258522A2 (en) | A method of controlling the oxidation of chemicals during storage using noble gases | |
US5382525A (en) | Method of effecting increased performance of diagnostic enzyme reaction systems using noble gases | |
Helber et al. | Regulation of nitrogenase gene expression in anaerobic cultures of Anabaena variabilis | |
Alston et al. | The water‐dependence of the catalytic activity of bilirubin oxidase suspensions in low‐water systems | |
Tanaka et al. | Nicked multifunctional loop of glutathione synthetase still protects the catalytic intermediate | |
Goh et al. | Investigation of lysine: N-hydroxylation in the biosynthesis of the siderophore aerobactin | |
Drenth et al. | The structure of the papain molecule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |